Exelixis
Trade Exelixis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About EXEL
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
EXEL Key Statistics
Stock Snapshot
The current Exelixis(EXEL) stock price is $45.24, with a market capitalization of 12.19B. The stock trades at a price-to-earnings (P/E) ratio of 18.56.
During the trading session on 2026-01-15, Exelixis(EXEL) shares reached a daily high of $45.84 and a low of $45.14. At a current price of $45.24, the stock is +0.2% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 2.27M, compared to an average daily volume of 2.56M.
Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $31.90.
Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $31.90.
EXEL News
Truist raised the firm’s price target on Exelixis (EXEL) to $51 from $49 and keeps a Buy rating on the shares after the company provided 2026 updated. The manag...
Exelixis recently released preliminary 2025 results, projecting total revenues of about US$2.32 billion and net product revenues of about US$2.12 billion, while...
U.S. stock futures were lower this morning, with the Dow futures falling more than 300 points on Monday. Shares of Exelixis Inc (NASDAQ:EXEL) fell sharply in p...
Analyst ratings
50%
of 22 ratingsMore EXEL News
Exelixis (EXEL) is back in focus after reporting strong phase 3 data for zanzalintinib in metastatic colorectal cancer, alongside launching the Natera partnersh...